Triple agonistPhase 3
Retatrutide
Retatrutide (investigational)
Subcutaneous injection · Once weekly
Investigational. No FDA-approved purchase option.
Drug class
The Triple agonist class
Triple agonist medications, with sourced prices, shortage reports and study results.
No FDA-approved GLP-1 in this category yet
The medications below are in late-stage development for it.
Investigational (pipeline)
Alphabetical by active ingredient. These entries are not FDA-approved for this category; open a record for the studied uses and evidence.
Study evidence & development
GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.